Search research articles
Contact Us
Filters
Showing results (171-180 of 542) with videos related to
Page
of 55
Sort By:
American Journal of Ophthalmology
|
January 15, 1989
Staphylococcus aureus conjunctivitis and sepsis in a neutropenic patient
M D Wolf, M A Pfaller, R J Hollis, et al.
Medical Care
|
June 1, 1987
Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections
D S Wakefield, M A Pfaller, G T Hammons, et al.
Diagnostic Microbiology and Infectious Disease
|
October 26, 1999
Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997
R N Jones, K C Kugler, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease
|
May 15, 2002
Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods
L M Deshpande, A M Fix, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 1995
Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions
M A Pfaller, J Rhine-Chalberg, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
April 1, 1995
Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit
D R Reagan, M A Pfaller, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy
|
February 8, 2017
<i>In Vitro</i> Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014
M A Pfaller, H S Sader, P R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
March 19, 2002
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000
M A Pfaller, S A Messer, R J Hollis, et al.
Diagnostic Microbiology and Infectious Disease
|
November 22, 2017
Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014)
M A Pfaller, P R Rhomberg, M D Huband, et al.
Diagnostic Microbiology and Infectious Disease
|
February 12, 1998
Growth medium effect on the antifungal activity of LY 303366
M E Klepser, E J Ernst, M E Ernst, et al.
Page
of 55
Search research articles
Search
Showing results (171-180 of 542) with videos related to
Sort By:
Page
of 55
American Journal of Ophthalmology
|
January 15, 1989
Staphylococcus aureus conjunctivitis and sepsis in a neutropenic patient
M D Wolf, M A Pfaller, R J Hollis, et al.
Medical Care
|
June 1, 1987
Use of the appropriateness evaluation protocol for estimating the incremental costs associated with nosocomial infections
D S Wakefield, M A Pfaller, G T Hammons, et al.
Diagnostic Microbiology and Infectious Disease
|
October 26, 1999
Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997
R N Jones, K C Kugler, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease
|
May 15, 2002
Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods
L M Deshpande, A M Fix, M A Pfaller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 1, 1995
Strain variation and antifungal susceptibility among bloodstream isolates of Candida species from 21 different medical institutions
M A Pfaller, J Rhine-Chalberg, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease
|
April 1, 1995
Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit
D R Reagan, M A Pfaller, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy
|
February 8, 2017
<i>In Vitro</i> Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014
M A Pfaller, H S Sader, P R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
March 19, 2002
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000
M A Pfaller, S A Messer, R J Hollis, et al.
Diagnostic Microbiology and Infectious Disease
|
November 22, 2017
Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014)
M A Pfaller, P R Rhomberg, M D Huband, et al.
Diagnostic Microbiology and Infectious Disease
|
February 12, 1998
Growth medium effect on the antifungal activity of LY 303366
M E Klepser, E J Ernst, M E Ernst, et al.
Page
of 55